Viromed Medical AG

Viromed Medical AG Successfully Completes Capital Increase | $DE.VME

Viromed Medical AG resolves to conduct a capital increase through a cash contribution, excluding shareholders' subscription rights | $DE.VME

HSV welcomes Viromed Medical GmbH as a new youth development partner

Viromed Medical GmbH has been supporting the youth teams of HSV since the 2026/27 season.

For the 2026/27 season, Hamburger SV is entering into a partnership with Viromed Medical GmbH. The medical technology company will be a partner of HSV's youth academy with immediate effect.

Above all, the company's innovation and its strong North German roots are connecting elements to the traditional club. Together, they aim to strengthen the development of young talent and bring about new perspectives.

Michael Scharold, Director of Partnerships and Marketing at HSV , expressed his delight at the merger: "Viromed stands for the courage to rethink medical solutions while keeping the concrete benefits for people in mind. Especially in youth development, where growth and the future play a daily role, this is an exciting partnership. We are eager to see what impetus will emerge from this new partnership."

“We are delighted to welcome Viromed as a partner of HSV’s youth academy. Together, we want to set new standards in the area of ​​youth development and fill the partnership with added value for both Viromed and HSV,” adds Johannes Haupt, Executive Director Team HSV at SPORTFIVE. | $DE.VME

Viromed Medical AG: Study on cold plasma application in the lung accepted for publication by an internationally leading medical journal | $DE.VME

Viromed Medical AG advances product development and market launch in the first half of 2026 and confirms full-year guidance | $DE.VME